In a development that marks China capitalizing on the coronavirus-driven COVID-19 pandemic, the Chinese government has made an investment in BGI Genomics Co, a Chinese listed company that supplies millions of COVID-19 tests globally. BGI is seeking to fund exponential… Read More ›